Use of Vitamins and their Derivates in the Treatment of Cutaneous Disorders

Authors

  • Andrea Chiricozzi Department of Dermatology, University of Rome Tor Vergata. Viale Oxford 81, 00133, Rome, Italy
  • Maria Sole Chimenti University of Rome Tor Vergata.
  • Mauro Bavetta Department of Dermatology, University of Rome Tor Vergata. Viale Oxford 81, 00133, Rome, Italy
  • Graziella Babino Department of Dermatology, University of Rome Tor Vergata. Viale Oxford 81, 00133, Rome, Italy
  • Sergio Chimenti Department of Dermatology, University of Rome Tor Vergata. Viale Oxford 81, 00133, Rome, Italy
  • Rosita Saraceno Department of Dermatology, University of Rome Tor Vergata. Viale Oxford 81, 00133, Rome, Italy

DOI:

https://doi.org/10.6000/1929-5634.2013.02.02.1

Keywords:

Vitamin deficiency, psoriasis, vitamin A, vitamin B, vitamin C, skin physiology

Abstract

Vitamins represent fundamental substrates for various physiologic functions occurring in human body. This review seeks to highlight their relevance in skin biology and to describe the cutaneous manifestations correlated with their deficiency.

Author Biography

Maria Sole Chimenti, University of Rome Tor Vergata.

Department of Rheumatology

References

Jen M, Yan AC. Syndrome associated with nutritional deficiency and excess. Clinics in Dermatology 2010; 28: 669-85. http://dx.doi.org/10.1016/j.clindermatol.2010.03.029

Brun PJ, Yang KJ, Lee SA, Yuen JJ, Blaner WS. Retinoids: Potent regulators of metabolism. Biofactors 2013; 39(2): 151-63. http://dx.doi.org/10.1002/biof.1056

Alvarez S, Bourguet W, Gronemeyer H, de Lera AR. Retinoic acid receptor modulators: a perspective on recent advances and promises. Expert Opin Ther Pat 2011; 21(1): 55-63. http://dx.doi.org/10.1517/13543776.2011.536531

Maire Al, Alvarez S, Shankaranarayanan P, Lera AR, Bourguet W, Gronemeyer H. Retinoid receptors and therapeutic applications of RAR/RXR modulators. Curr Top Med Chem 2012; 12(6): 505-27. http://dx.doi.org/10.2174/156802612799436687

Mihály J, Gericke J, Aydemir G, Weiss K, Carlsen H, Blomhoff R, et al. Reduced retinoid signaling in the skin after systemic retinoid-X receptor ligand treatment in mice with potential relevance for skin disorders. Dermatology 2012; 225(4): 304-11 http://dx.doi.org/10.1159/000345496

Steinemann T, Christiansen S. Vitamin A deficiency and xerophthalmia in an autistic child. Arch Ophthalmol 1998; 116: 392-3. http://dx.doi.org/10.1001/archopht.116.3.392

Sherwin JC, Reacher MH, Dean WH, Ngondi J. Epidemiology of vitamin A deficiency and xerophthalmia in at-risk populations. Trans R Soc Trop Med Hyg 2012; 106(4): 205-14. http://dx.doi.org/10.1016/j.trstmh.2012.01.004

Ragunatha S, Kumar VJ, Murugesh SB. A clinical study of 125 patients with phrynoderma. Indian J Dermatol 2011; 56(4): 389-92. http://dx.doi.org/10.4103/0019-5154.84760

Chia MW, Tay YK, Liu TT. Phrynoderma: a forgotten entity in a developed country. Singapore Med J 2008; 49(6): e160-2. http://www.ncbi.nlm.nih.gov/pubmed/18581010

Heath ML, Sidbury L. Cutaneous manifestation of nutritional deficiency. Curr Opin Pediatr 2006; 18(4): 417-22. http://dx.doi.org/10.1097/01.mop.0000236392.87203.cc

Maroon M, Allen DM, Esterly NB. Phrynoderma: a manifestation of vitamin A deficiency? The rest of the story. Pediatr Dermatol 2005; 22(1): 60-3. http://dx.doi.org/10.1111/j.1525-1470.2005.22113.x

Goldberg JL, Lenzy Y. Nutrition and hair. Clin Dermatol 2010; 28: 412-9. http://dx.doi.org/10.1016/j.clindermatol.2010.03.038

Fuchs J. Alcoholism, malnutrition, vitamin deficiencies, and the skin. Clin Dermatol 1999; 17: 457-61. http://dx.doi.org/10.1016/S0738-081X(99)00032-2

Nicol NJ, Fenske NA. Photodamage: cause clinical manifestations, and prevention. Dermatol Nurs 1993; 5(4): 263-75; quiz 276-7.

Fisher GJ, Datta SC, Talwar HS, Wang ZQ, Varani J, Kang S, Voorhees JJ. Molecular basis of sun-induced premature skin aging and retinoid antagonism. Nature 1996; 379(6563): 335-9. http://dx.doi.org/10.1038/379335a0

Elson ML. Topical tretinoin in the treatment of striae distensae and in the promotion of wound healing: a review. J Dermatol Treat 1994; 5(3): 163-5. http://dx.doi.org/10.3109/09546639409084563

Kang S, Kim KJ, Griffiths CE, Wong TY, Talwar HS, Fisher GJ, et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol 1996; 132 (5): 519-26. http://dx.doi.org/10.1001/archderm.1996.03890290053007

Zheng P, Lavkar RM, Kligman AM. Anatomy of striae. Br J Dermatol 1985; 112(2): 185-93. http://dx.doi.org/10.1111/j.1365-2133.1985.tb00082.x

Kligman AM, Pagnoni A, Stoudemayer T. Topical retinol improves cellulite. J Dermatol Treat 1999; 10(2): 119-25.

Hunt TK. Vitamin A and wound healing. J Am Acad Dermatol 1986; 15: 817-21. http://dx.doi.org/10.1016/S0190-9622(86)70238-7

Christiansen JV, Gadborg E, Ludvigsen K, Meier CH, Norholm A, et al. Topical tretinoin, vitamin A acid (Airol) in acne vulgaris. A controlled clinical trial. Dermatologica 1974; 148(2): 82-9. http://dx.doi.org/10.1159/000251602

Layton AM, Stainforth JM, Cunliffe WJ. Ten years’ experience of oral isotretinoin for the treatment of acne vulgaris. J Dermatol Treat 1993; 4: S2. http://dx.doi.org/10.3109/09546639309082157

Leyden JJ, McGinley KJ, Foglia AN. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobate. J Invest Dermatol 1986; 86: 390-3. http://dx.doi.org/10.1111/1523-1747.ep12285658

Strauss JS, Rapini RP, Shalita AR, Konecky E, Pochi PE, Comite H, Exner JH. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984; 10 (3): 490-6. http://dx.doi.org/10.1016/S0190-9622(84)80100-0

Plewig G, Nikolowski J, Wolff HH. Action of isotretinoin in acne rosacea and gram-negative folliculitis. J Am Acad Dermatol 1982; 6: 766-85. http://dx.doi.org/10.1016/S0190-9622(82)70067-2

Löwhagen GB, Michaëlsson G, Mobacken H, Pettersson U, Vahlquist A. Effects of etretinate (Ro 10-9359) on Darier’s disease. Dermatologica 1982; 165(2): 123-30. http://dx.doi.org/10.1159/000249930

Blanchet-Bardon C, Nazzaro V, Rognin C, Geiger JM, Puissant A. Acitretin in the treatment of severe disorders of keratinization: results of an open study. J Am Acad Dermatol 1991; 24: 982-6. http://dx.doi.org/10.1016/0190-9622(91)70158-X

Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis-retinoic acid (isotretinoin). J Am Acad Dermatol 1982; 6: 710-5. http://dx.doi.org/10.1016/S0190-9622(82)70061-1

Borok M, Lowe NJ. Pityriasis rubra pilaris: further observations of systemic retinoid therapy. J Am Acad Dermatol 1990; 22: 792-5. http://dx.doi.org/10.1016/0190-9622(90)70110-4

Cohen PR, Prystowsky JH. Pityriasis rubra pilaris: a review of diagnosis and treatment. J Am Acad Dermatol 1989; 20: 801-7. http://dx.doi.org/10.1016/S0190-9622(89)70093-1

Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997; 337: 1419-28. http://dx.doi.org/10.1056/NEJM199711133372003

Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15(4 Pt 2): 836-59. http://dx.doi.org/10.1016/S0190-9622(86)70242-9

Weinstein GD, Nigra TP, Pochi PE, Savin RC, Allan A, et al. Topical tretinoin for treatment of photodamaged skin: a multicenter study. Arch Dermatol 1991; 27(5): 659-65. http://dx.doi.org/10.1001/archderm.1991.01680040067005

Lippman SM, Shimm DS, Meyskens FL Jr. Nonsurgical treatments for skin cancer: retinoids and alpha-interferon. J Dermatol Surg Oncol 1988; 14: 862-9.

Alirezai M, Dupuy P, Amblard P, Kalis B, Souteyrand P, Frappaz A, Sendagorta E. Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 1994; 30: 447-51. http://dx.doi.org/10.1016/S0190-9622(94)70054-0

Tangrea JA, Edwards BK, Taylor PR, Hartman AM, Peck GL, Salasche SJ, et al. Long-term therapy with low dose isotretinoin for prevention of basal cell carcinoma: a multicenter trial. J Natl Cancer Inst 1992; 84: 328-32. http://dx.doi.org/10.1093/jnci/84.5.328

Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633-7. http://dx.doi.org/10.1056/NEJM198806233182501

Bailly C, Drèze S, Asselineau D, Nusgens B, Lapière CM, Darmon M. Retinoic acid inhibits the production of collagenase by human epidermal keratinocytes. J Invest Dermatol 1990; 94: 47-51. http://dx.doi.org/10.1111/1523-1747.ep12873342

Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwhol MG, Bebo BF Jr, Kalb RE. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2012; 67(2): 279-88. http://dx.doi.org/10.1016/j.jaad.2011.01.032

Arechalde A, Saurat HJ. Management of psoriasis: the position of retinoid drugs. BioDrugs 2000; 13(5): 327-33. http://dx.doi.org/10.2165/00063030-200013050-00003

Orfanos CE. Treatment of psoriasis with retinoids: present status. Cutis 1999; 64(5): 347-53.

Ling MR. Acitretin: optimal dosing strategies. J Am Acad Dermatol 1999; 41(3 pt 2): S13-7.

Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol 1999; 41(3 pt 2): S7-S12.

Gollnick HP. Oral retinoids—efficacy and toxicity in psoriasis. Br J Dermatol 1996; 135(Suppl 49): 6-17. http://dx.doi.org/10.1111/j.1365-2133.1996.tb15661.x

Gisondi P, Fantuzzi F, Malerba M, Girolomoni G. Folic acid in general medicine and dermatology. J Dermatolog Treat 2007; 18(3): 138-46. http://dx.doi.org/10.1080/09546630701247930

Lansdown ABG. Nutrition 2: a vital consideration in the management of wounds. Br J Nurs 2004; 13: 1199-10.

Fuchs J. Alcoholism, malnutrition, vitamin deficiencies, and the skin. Clin Dermatol 1999; 17: 457-61. http://dx.doi.org/10.1016/S0738-081X(99)00032-2

Alvarez OM, Gillbreath RI. Thiamine influence on collagen during granulation of skin wounds. J Surg Res 1982; 32: 24-31. http://dx.doi.org/10.1016/0022-4804(82)90180-9

Abbas CA, Sibirny AA. Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev 2011; 75(2): 321-60. http://dx.doi.org/10.1128/MMBR.00030-10

Roe D. Riboflavin deficiency: mucocutaneous signs of acute and chronic deficiency. Semin Dermatol 1991; 10: 293-5.

Lanska DJ. The discovery of niacin, biotin, and pantothenic Acid. Ann Nutr Metab 2012; 61(3): 246-53. http://dx.doi.org/10.1159/000343115

Cakmak SKM, Gönül M, Aslan E, Gül U, Kiliç A, Heper AO. Halfand- half nail in a case of pellagra. Eur J Dermatol 2006; 16: 695-6.

Hendricks WM. Pellagra and pellagra-like dermatoses: Etiology, differential diagnosis dermatopothology, and treatment. Semin Dermatol 1991; 10: 282-9.

Brown TM. Pellagra: an old enemy of timeless importance. Psychosomatics 2010; 51(2): 93-7.

Barthelemy H, Chouvet B, Cambazard F. Skin and mucosal manifestations in vitamin deficiency. J Am Acad Dermatol 1986; 15(6): 1263-74. http://dx.doi.org/10.1016/S0190-9622(86)70301-0

Inubushi T, Takasawa T, Tuboi Y, Watanabe N, Aki K, Katunuma N. Changes of glucose metabolism and skin-collagen neogenesis in vitamin B6 deficiency. Biofactors 2005; 23(2): 59-67. http://dx.doi.org/10.1002/biof.5520230201

O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients 2010; 2(3): 299-316. http://dx.doi.org/10.3390/nu2030299

Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol 2010; 148(2): 195-204. http://dx.doi.org/10.1111/j.1365-2141.2009.07937.x

Baumslag N, Metz J. Pigmentation in megaloblastic anaemia associated with pregnancy and lactation. Br Med J 1969; 2: 737-9. http://dx.doi.org/10.1136/bmj.2.5659.737

Noppakun N, Swasdikul D. Reversible hyperpigmentation of skin and nails with white hair due to vitamin B12 deficiency. Arch Dermatol 1986; 122: 896-9. http://dx.doi.org/10.1001/archderm.1986.01660200068018

Mori K, Ando I, Kukita A. Generalized hyperpigmentation of the skin due to vitamin B12 deficiency. J Dermatol 2001; 28: 282-5.

Crawford JR, Say D. Vitamin B12 deficiency presenting as acute ataxia. BMJ Case Rep 2013; 2013. doi:pii: bcr2013008840. http://casereports.bmj.com/content/2013/ bcr-2013-008840.long

Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988; 318(26): 1720-8. http://dx.doi.org/10.1056/NEJM198806303182604

Sakane T, Takada S, Kotani H, Tsunematsu T. Effects of methyl-B12 on the in vitro immune functions of human T lymphocytes. J Clin Immunol 1982; 2: 101-9. http://dx.doi.org/10.1007/BF00916893

Yamashiki M, Nishimura A, Koska Y. Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells. J Clin Lab Immunol 1992; 37: 173-82.

Brazzelli V, Grasso V, Fornara L, Moggio E, Gamba G, Villani S, Borroni G. Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol 2010; 23(3): 911-6.

Rimbaud P, Ravoire J, Rioux J. Treatment of psoriasis by vitamine B12 with 1,000 gammas. Bull Soc Fr Dermatol Syphiligr 1955; 5: 509-10.

Miura T, Torinuki W, Makino Y. Treatment of pustulosis palmaris et plantaris with large doses of vitamin B12. J Dermatol 1976; 3(4): 155-8.

Stücker M, Memmel U, Hoffmann M, Hartung J, Altmeyer P. Vitamin B12 cream containing avocado oil in the therapy of plaque psoriasis. Dermatology 2001; 203: 141-7. http://dx.doi.org/10.1159/000051729

Levine M. New concepts in the biology and biochemistry of ascorbic acid. New Engl J Med 1986; 314: 892-902. http://dx.doi.org/10.1056/NEJM198604033141407

Wefers H, Sies H. The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on Vitamin E. Eur J Biochem 1988; 174: 353-7. http://dx.doi.org/10.1111/j.1432-1033.1988.tb14105.x

Scarpa M, Stevenato R, Viglino Rigo A. Superoxide ionas active intermediate in the autoxidation of ascorbate by molecular oxygen: effect of superoxide dismutase. J Biol Chem 1983; 258: 6695-7.

Cabelli DE, Bielski BHJ. Kinetics and mechanism for the oxidation of ascorbic acid/ascorbate by HO2/O2 radicals: a pulse radiolysis and stopped flow photolysis study. J Phys Chem 1983; 87: 1805-12. http://dx.doi.org/10.1021/j100233a031

Chou PT, Khan AU. L-ascorbic acid quenching of singlet delta molecular oxygen in aqueous media: generalized

antioxidant property of vitamin C. Biochem Biophys Res Commun 1983; 115: 932-7. http://dx.doi.org/10.1016/S0006-291X(83)80024-2

McCay PB. Vitamin E: interactions with free radicals and ascorbate. Annu Rev Nutr 1985; 5: 323-40. http://dx.doi.org/10.1146/annurev.nu.05.070185.001543

Ponec M, Weerheim A, Kempenaar J, Mulder A, Gooris GS, Bouwstra J, et al. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997; 109(3): 348-55. http://dx.doi.org/10.1111/1523-1747.ep12336024

Phillips CL, Combs SB, Pinnell SR. Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. J Invest Dermatol 1994; 103: 228-32. http://dx.doi.org/10.1111/1523-1747.ep12393187

Murad S, Grove D, Lindberg KA, et al. Regulation of collagen synthesis by ascorbic acid. Proc Natl Acad Sci USA 1981; 78(5): 2879-82. http://dx.doi.org/10.1073/pnas.78.5.2879

Lansdown ABG. Nutrition 2: a vital consideration in the management of wounds. Br J Nurs 2004; 13: 1199-10.

Levenson SM, Demetriou AA. Metabolic factors. In: Cohen IK, Diegelmann R, Lindblad WJ, Eds. Wound healing: biochemical and clinical aspects. Philadelphia: Saunders; 1992; pp. 248-73.

Bourne GH. Effect of vitamin C deficiency on experimental wounds: tensile strength and histology. Lancet 1944; 1: 688-92. http://dx.doi.org/10.1016/S0140-6736(00)74919-1

Martí N, Mena P, Cánovas JA, Micol V, Saura D. Vitamin C and the role of citrus juices as functional food. Nat Prod Commun 2009; 4(5): 677-700.

Baron JH. Sailors' scurvy before and after James Lind--a reassessment. Nutr Rev 2009; 67(6): 315-32. http://dx.doi.org/10.1111/j.1753-4887.2009.00205.x

Woodier N, Koytzoumis V. 'Scurvy': presentation and skin manifestations of a not so uncommon condition. Emerg Med J 2012; 29(2): 103. http://dx.doi.org/10.1136/emermed-2011-200417

Firth N, Marvan E. Oral lesions in scurvy. Aust Dent J 2001; 46(4): 298-300. http://dx.doi.org/10.1111/j.1834-7819.2001.tb00294.x

Touyz LZ. Oral scurvy and periodontal disease. J Can Dent Assoc 1997; 63(11): 837-45.

Hood J, Burns CA, Hodges RE. Sjögren's syndrome in scurvy. N Engl J Med 1970; 282(20): 1120-4. http://dx.doi.org/10.1056/NEJM197005142822003

Hood J, Hodges RE. Ocular lesions in scurvy. Am J Clin Nutr 1969; 22(5): 559-67. http://ajcn.nutrition.org/content/22/5/ 559.long

Fain O. Vitamin C deficiency. Rev Med Interne 2004; 25(12): 872-80. http://dx.doi.org/10.1016/j.revmed.2004.03.009

Wei Q, Matanoski GM, Farmer ER, Strickland P, Grossman L. Vitamin supplementation and reduced risk of basal cell carcinoma. J Clin Epidemiol 1994; 47: 829-36. http://dx.doi.org/10.1016/0895-4356(94)90185-6

Miyai E, Yanagida M, Akiyama J, Yamamoto I. Ascorbic acid 2-Oalpha-glucoside-induced redox modulation in human keratinocyte cell line, SCC: mechanisms of photoprotective effect against ultraviolet light B. Biol Pharm Bull 1997; 20: 632-6. http://dx.doi.org/10.1248/bpb.20.632

Bialy TL, Rothe MJ, Grant-Kels JM. Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. Dermatol Surg 2002; 28(12): 1143-52. http://dx.doi.org/10.1046/j.1524-4725.2002.02114.x

Moison RM, Beijersbergen van Henegouwen GM. Topical antioxidant vitamins C and E prevent UVB-radiation-induced peroxidation of eicosapentaenoic acid in pig skin. Radiat Res 2002; 157: 402-9. http://dx.doi.org/10.1667/0033-7587(2002)157[0402:TAVCAE]2.0.CO;2

Lupulescu A, Vitamin C inhibits DNA. RNA and protein synthesis in epithelial neoplastic cells. Int J Vitam Nutr Res 1991; 61: 125-9.

Pauling L, Willoughby R, Reynolds R, Blaisdell BE, Lawson S. Incidence of squamous cell carcinoma in hairless mice irradiated with ultraviolet light in relation to intake of ascorbic acid (vitamin C) and of D, L-alpha-tocopheryl acetate (vitamin E). Int J Vitam Nutr Res Suppl 1982; 23: 53-82.

van Dam RM, Huang Z, Giovannucci E, Rimm EB, Hunter DJ, Colditz GA, et al. Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr 2000; 71: 135-41. http://ajcn.nutrition.org/content/71/1/135.long

Fung TT, Spiegelman D, Egan KM, Giovannucci E, Hunter DJ, Willett WC. Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer 2003; 103: 110-5. http://dx.doi.org/10.1002/ijc.10798

Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green AC, van der Pols JC. Intake of antioxidant nutrients and the risk of skin cancer. Eur J Cancer 2007; 43: 2707-16. http://dx.doi.org/10.1016/j.ejca.2007.09.005

Phillips C, Pinnell SR. Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. Soc Invest Dermatol 1994; 103: 228-32. http://dx.doi.org/10.1111/1523-1747.ep12393187

Finglas PM, Bailey A, Walker A, Loughridge JM, Wright AJ, Southon S. Vitamin C intake and plasma ascorbic acid concentration in adolescents. Br J Nutr 1993; 69: 563-76. http://dx.doi.org/10.1079/BJN19930056

Fenske NA, Lober CW. Structural and functional changes of normal aging skin. J Am Acad Dermatol 1986; 15: 571-85. http://dx.doi.org/10.1016/S0190-9622(86)70208-9

Leibovitz BE, Siegel BV. Aspects of free radical reactions in biological systems: aging. J Gerontol 1980; 35: 45-56. http://dx.doi.org/10.1093/geronj/35.1.45

Darr D, Combs S, Dunston S, Manning T, Pinnell S. Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage. Br J Dermatol 1992; 127: 247-53. http://dx.doi.org/10.1111/j.1365-2133.1992.tb00122.x

Murray J, Darr D, Reich J, Pinnell S. Topical vitamin C treatment reduces ultraviolet B radiation-induced erythema in human skin. J Invest Dermatol 1991; 96: 587.

Kameyama K, Sakai C, Kondoh S, Yonemoto K, Nishiyama S, Tagawa M, et al. Inhibitory effects of magnesium L-ascorbyl-2-phosphate on melanogenesis in vitro and in vivo. J Am Acad Dermatol 1996; 34: 29-33. http://dx.doi.org/10.1016/S0190-9622(96)90830-0

Lu Z, Chen TC, Zhang A, Persons KS, Kohn N, Berkowitz R, et al. An evaluation of the vitamin D3 content in fish. J Steroid Biochem Mol Biol 2007; 103: 642-4. http://dx.doi.org/10.1016/j.jsbmb.2006.12.010

Dietary reference intakes. National Academy of Sciences. Washington, DC: National Academy Press 1997. http://www.nap.edu/openbook.php?record_id=13050

Cline J. Calcium and vitamin d metabolism, deficiency, and excess. Top Companion Anim Med 2012; 27(4): 159-64. http://dx.doi.org/10.1053/j.tcam.2012.09.004

Ponchon G, Kennan AL, DeLuca HF. “Activation” of vitamin D by the liver. J Clin Invest 1969; 48: 2032-7. http://dx.doi.org/10.1172/JCI106168

Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature 1970; 228(5273): 764-6. http://dx.doi.org/10.1038/228764a0

Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007; 24: 1017-29. http://dx.doi.org/10.2165/00002512-200724120-00005

Cashman KD. Calcium and vitamin D. Novartis Food Symp 2007; 282: 123-38.

Guasch A, Bulló M, Rabassa A, Bonada A, Del Castillo D, Sabench F, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol 2012; 11: 149. http://dx.doi.org/10.1186/1475-2840-11-149

Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 2010; 33: 2021-23. http://dx.doi.org/10.2337/dc10-0790

Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010; 33(2): 344-47. http://dx.doi.org/10.2337/dc09-0924

Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian diabetes, obesity and lifestyle study). Diabetes Care 2011; 34(5): 1133-38. http://dx.doi.org/10.2337/dc10-2167

Bhandari SK, Pashayan S, Liu IL, Rasgon SA, Kujubu DA, Tom TY, et al. 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich) 2011; 13(3): 170-77. http://dx.doi.org/10.1111/j.1751-7176.2010.00408.x

Karhapaa P, Pihlajamaki J, Porsti I, Kastarinen M, Mustonen J, Niemela O, et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010; 268(6): 604-10. http://dx.doi.org/10.1111/j.1365-2796.2010.02279.x

Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 10(6): 798-805. http://dx.doi.org/10.1016/j.amjcard.2010.04.042

Pilz S, van den Hurk K, Nijpels G, Stehouwer CD, Van’t Riet E, Kienreich K, et al. Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: the Hoorn study. Nutr Metab Cardiovasc Dis 2012; 22: 833-39. http://dx.doi.org/10.1016/j.numecd.2012.03.008

Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57(2): 298-305. http://dx.doi.org/10.2337/db07-1122

Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72(3): 690-93.

Drincic AT, Armas LA, Van Diest EE, Heaney RP. Volumetric Dilution, Rather Than Sequestration Best Explains the Low Vitamin D Status of Obesity. Obesity (Silver Spring) 2012; 20(7): 1444-48. http://dx.doi.org/10.1038/oby.2011.404

Kull M, Kallikorm R, Lember M. Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 2009; 39(4): 256-58. http://dx.doi.org/10.1111/j.1445-5994.2009.01900.x

Shahriari M, Kerr PE, Slade K, Grant-Kels JE. Vitamin D and the skin. Clin Dermatol 2010; 28(6): 663-8. http://dx.doi.org/10.1016/j.clindermatol.2010.03.030

Hawker NP, Pennypacker SD, Chang SM,. Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. J Invest Dermatol 2007; 127(4): 874-80. Epub 2006 Nov 2. http://dx.doi.org/10.1038/sj.jid.5700624

Popadic S, Ramic Z, Medenica L, Mostarica Stojkovic M, Trajković V, Popadic D. Antiproliferative effect of vitamin A and D analogues on adult human keratinocytes in vitro. Skin Pharmacol Physiol 2008; 21(4): 227-34. http://dx.doi.org/10.1159/000135639

Tiberio R, Bozzo C, Pertusi G, Graziola F, Gattoni M, Griffanti P, et al. Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol 2009; 34(8): e972-4. http://dx.doi.org/10.1111/j.1365-2230.2009.03518.x

Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002; 2: 1017-28. http://dx.doi.org/10.1016/S1567-5769(02)00049-8

Leone G, Pacifico A. Profile of clinical efficacy and safety of topical tacalcitol. Acta Biomed 2005; 76(1): 13-9.

Fogh K, Kragballe K. New vitamin D analogs in psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 199-204. http://dx.doi.org/10.2174/1568010043343930

Segaert S, Duvold LB. Calcipotriol cream: a review of its use in the management of psoriasis. J Dermatolog Treat 2006; 17(6): 327-37. http://dx.doi.org/10.1080/09546630600999219

Bos JD, Spuls PI. Topical treatments in psoriasis: today and tomorrow. Clin Dermatol 2008; 26: 432-7. http://dx.doi.org/10.1016/j.clindermatol.2007.10.025

Morimoto S, Kumahara Y. A patient with psoriasis cured by 1 alphahydroxyvitamin D3. Med J Osaka Univ 1985; 35: 51-4.

Morimoto S, Yoshikawa K, Kozuka T, Kitano Y, Imanaka S, Fukuo K, et al. Treatment of psoriasis vulgaris with oral 1alpha,25-dihydroxyvitamin D3-report of two cases. J Dermatol 1987; 14: 59-62.

Smith EL, Pincus SH, Donovan L, Holick MF. A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 1988; 19: 516-28. http://dx.doi.org/10.1016/S0190-9622(88)70207-8

Huckins D, Felson DT, Holick M. Treatment of psoriatic arthritis with oral 1-25 dihydroxyvitamin D3: a pilot study. Arthritis Rheum 1990; 1723-7. http://dx.doi.org/10.1002/art.1780331117

el-Azhary RA, Peters MS, Pittelkow MR, Kao PC, Muller SA. Efficacy of vitamin D3 derivatives in the treatment of psoriasis vulgaris: a preliminary report. Mayo Clin Proc 1993; 68: 835-41. http://dx.doi.org/10.1016/S0025-6196(12)60690-9

Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998; 39(2 Pt 1): 211-5. http://dx.doi.org/10.1016/S0190-9622(98)70077-5

Tay YK. Topical calcipotriol ointment in the treatment of morphea. J Dermatolog Treat 2003; 14(4): 219-21. http://dx.doi.org/10.1080/09546630310015449

Kreuter A, Gambichler T, Sauermann K, Jansen T, Altmeyer P, Hoffmann K. Extragenital lichen sclerosus successfully treated with topical calcipotriol: evaluation by in vivo confocal laser scanning microscopy. Br J Dermatol 2002; 146(2): 332-3. http://dx.doi.org/10.1046/j.1365-2133.2002.4653_3.x

Marini A, Blecken S, Ruzicka T, Hengge UR. Lichen sclerosus. New aspects of pathogenesis and treatment. Hautarzt 2005; 56(6): 550-5. http://dx.doi.org/10.1007/s00105-005-0955-0

Gupta S, Saraswat A, Kumar B. Treatment of genital lichen sclerosus with topical calcipotriol. Int J STD AIDS 2005; 16(11): 772-4. http://dx.doi.org/10.1258/095646205774763234

Newton-Bishop JA, Beswick S, Randerson-Moor J, Chang YM, Affleck P, Elliott F, et al. Serum 25- hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009; 27: 5439-44. http://dx.doi.org/10.1200/JCO.2009.22.1135

Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 2009; 45: 3271-81. http://dx.doi.org/10.1016/j.ejca.2009.06.011

Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol 2009; 129: 1675-80. http://dx.doi.org/10.1038/jid.2008.451

Ratnam AV, Bikle DD, Cho JK. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes. J Cell Physiol 1999; 178: 188-96. http://dx.doi.org/10.1002/(SICI)1097-4652(199902)178:2<188::AID-JCP8>3.0.CO;2-4

Kamradt J, Rafi L, Mitschele T, Meineke V, Gärtner BC, Wolfgang T, et al. Analysis of the vitamin D system in cutaneous malignancies. Recent Results Cancer Res 2003; 164: 259-69. http://dx.doi.org/10.1007/978-3-642-55580-0_19

Smith EL, Walworth NC, Holick MF. Effect of 1 alpha,25- dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-14. http://dx.doi.org/10.1111/1523-1747.ep12276343

Gniadecki R. Stimulation versus inhibition of keratinocyte growth by 1,25-dihydroxyvitamin D3: Dependence on cell culture conditions. J Invest Dermatol 1996; 106: 510-6. http://dx.doi.org/10.1111/1523-1747.ep12343866

Smit JV, Cox S, Blokx WA, van de Kerhof PC, de Jongh GJ, de Jong EM. Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period. Br J Dermatol 2002; 147: 816-8. http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2133.2002.49297.x/abstract

Seckin D, Cerman AA, Yildiz A, Ergun T. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report. J Drugs Dermatol 2009; 8: 451-4.

van Dam RM, Huang Z, Giovannucci E, Rimm EB, Hunter DJ, Colditz GA, et al. Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr 2000; 71: 135-41. http://ajcn.nutrition.org/content/71/1/135.long

Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. Ann Epidemiol 1992; 2: 231-9. http://dx.doi.org/10.1016/1047-2797(92)90055-U

Davies TW, Treasure FP, Welch AA, Day NE. Diet and basal cell skin cancer: results from the EPIC-norfolk cohort. Br J Dermatol 2002; 146: 1017-22. http://dx.doi.org/10.1046/j.1365-2133.2002.04763.x

Traber MG, Sies H. Vitamin E in humans: demand and delivery. Annu Rev Nutr 1996; 16: 321-47. http://dx.doi.org/10.1146/annurev.nu.16.070196.001541

Kitagawa M, Mino M. Effects of elevated d-alpha-tocopherol dosage in man. J Nutri Sci Vitaminol (Tokyo) 1989; 35: 133-42. http://dx.doi.org/10.3177/jnsv.35.133

Nachbar F, Korting HC. The role of vitamin E in normal and damaged skin. J Mol Med 1995; 73: 7-17. http://dx.doi.org/10.1007/BF00203614

Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamin: vitamins E and C, beta-carotene, and other carotenoids. Ann NY Acad Sci 1992; 669: 7-20. http://dx.doi.org/10.1111/j.1749-6632.1992.tb17085.x

Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996; 31: 671-701. http://dx.doi.org/10.1007/BF02522884

Tsoureli-Nikita E, Hercogova J, Lotti T, Menchini G. Evaluation of dietary intake of vitamin E in the treatment of atopic dermatitis: a study of the clinical course and evaluation of the immunoglobulin E serum levels. Int J Dermatol 2002; 41: 146-50. http://dx.doi.org/10.1046/j.1365-4362.2002.01423.x

Pathak MA, Carbonare MD. Photoaging and the role of mammalian skin superoxide dismutase and antioxidants. Photochem Photobiol 1988; 47: 7S.

Bissett DL, Majeti S, Fu JJ, McBride JF, Wyder WE. Protective effect of topically applied conjugated hexadienes against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 1990; 7: 63-7.

Beijersbergen van Henegouwen GMJ, Junginger HE, de Vries H. Hydrolysis of RRR-α tocopheryl acetate (vitamin E acetate) in the skin and its UV protecting activity (an in vivo study with the rat). J Photochem Photobiol B Biol 1995; 29: 45-51. http://dx.doi.org/10.1016/1011-1344(95)90251-1

Bissett DL, Chatterjee R, Hannon DP. Protective effect of a topically applied anti-oxidant plus an anti-inflammatory agent against ultraviolet radiation-induced chronic skin damage in the hairless mouse. J Soc Cosmet Chem 1992; 43: 85-92.

Bissett DL, Chatterjee R, Hannon DP. Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiationinduced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 1990; 7: 56-62.

Jurkiewicz BA, Bissett DL, Buettner GR. Effect of topically applied tocopherol on ultraviolet radiation-mediated free radical damage in skin. J Invest Dermatol 1995; 104: 484-8. http://dx.doi.org/10.1111/1523-1747.ep12605921

Burke KE, Clive J, Combs GF Jr, Commisso J, Keen CL, Nakamura RM. Effects of topical and oral vitamin E on pigmentation and skin cancer induced by ultraviolet irradiation in Skh: 2 hairless mice. Nutr Cancer 2000; 38: 87-97. http://dx.doi.org/10.1207/S15327914NC381_13

Record IR, Dreosti IE, Konstantinopoulos M, Buckley RA. The influence of topical and systemic vitamin E on ultraviolet light-induced skin damage in hairless mice. Nutr Cancer 1991; 16: 219-26. http://dx.doi.org/10.1080/01635589109514160

Trevithick JR, Xiong H, Lee S, Shum DT, Sanford SE, Karlik SJ, et al. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice. Arch Biochem Biophys 1992; 296: 575-82. http://dx.doi.org/10.1016/0003-9861(92)90613-2

Trevithick JR, Shum DT, Redae S, Mitton KP, Norley C, Karlik SJ, et al. Reduction of sunburn damage to skin by topical application of vitamin E acetate following exposure to ultraviolet B radiation: effect of delaying application or of reducing concentration of vitamin E acetate applied. Scan Microsc 1993; 7: 1269-81.

Brenner S, Horwitz C. Possible nutrient mediators in psoriasis and seborrheic dermatitis. II. Nutrient mediators: essential fatty acids; vitamins A, E and D; vitamins B1, B2, B6, niacin and biotin; vitamin C selenium; zinc; iron. World Rev Nutr Diet 1988; 55: 165-82.

Arutiunov VIa, Gutman SE. Experience in treating certain alopecias with liquid nitrogen and vitamins A and E. Sov Med 1972; 35(4): 126-30.

McGee P. Vitamin E and pruritus. Can Nurse 2001; 97(1): 8.

Budeguer MA. Treatment of genital pruritus with vitamin E Dia Med 1950; 22(66): 2772-6.

Parsa FD. Vitamin E: facts and fallacies. Plast Reconstr Surg 1988; 81: 300-1. http://dx.doi.org/10.1097/00006534-198802000-00045

Lee M. An investigation into the value of d,l-alpha-tocopheryl acetate (vitamin E) in the treatment of gravitational ulcers. Br J Dermatol 1953; 65: 131-8. http://dx.doi.org/10.1111/j.1365-2133.1953.tb15677.x

Musalmah M, Fairuz AH, Gapor MT, Ngah WZ. Effect of vitamin E on plasma malondialdehyde, antioxidant enzyme levels and the rates of wound closures during wound healing in normal and diabetic rats. Asia Pac J Clin Nutr 2002; 11(Suppl 7): 448-51. http://dx.doi.org/10.1046/j.1440-6047.11.s.7.6.x

Gray M. Does oral supplementation with vitamins A or E promote healing of chronic wounds? J Wound Ostomy Continence Nurs 2003; 30(6): 290-4. http://www. sciencedirect.com/science/article/pii/S1071575403005163

Rashid SA, Halim AS, Muhammad NA. The effect of vitamin E on basic fibroblast growth factor level in human fibroblast cell culture. Med J Malaysia 2008; 63(Suppl A): 69-70.

Baumann LS, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg 1999; 25(4): 311-15. http://dx.doi.org/10.1046/j.1524-4725.1999.08223.x

Chang CW, Ries WR. Nonoperative techniques for scar management and revision. Facial Plast Surg 2001; 17(4): 283-288. http://dx.doi.org/10.1055/s-2001-18826

Palmieri B, Gozzi G, Palmieri G. Vitamin E added silicon gel sheets for treatment of hypertrophic scars and keloids. Int J Dermatol 1995; 34(7): 506-509. http://dx.doi.org/10.1111/j.1365-4362.1995.tb00628.x

Lopez-Torres M, Thiele JJ, Shindo Y, Han D, Packer L. Topical application of alpha-tocopherol modulates the antioxidant network and diminishes ultravioletinduced oxidative damage in murine skin. Br J Dermatol 1998; 138: 207-15. http://dx.doi.org/10.1046/j.1365-2133.1998.02062.x

Yuen KS, Halliday GM. Alpha-tocopherol, an inhibitor of epidermal lipid peroxidation, prevents ultraviolet radiation from suppressing the skin immune system. Photochem Photobiol 1997; 65: 587-92. http://dx.doi.org/10.1111/j.1751-1097.1997.tb08610.x

Gensler HL, Magdaleno M. Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet irradiation. Nutr Cancer 1991; 15: 97-106. http://dx.doi.org/10.1080/01635589109514117

Steenvoorden DP, Beijersbergen van Henegouwen GMJ. The use of endogenous antioxidants to improve photoprotection. J Photochem Photobiol B 1997; 41 (1-2): 1-10. http://dx.doi.org/10.1016/S1011-1344(97)00081-X

Kagan V, Witt E, Goldman R, Scita G, Packer L. Ultraviolet light-induced generation of vitamin E radicals and their recycling. A possible photosensitizing effect of vitamin E in skin. Free Radic Res Commun 1992; 16 (1): 51-64. http://dx.doi.org/10.3109/10715769209049159

Jurkiewicz BA, Bissett DL, Buettner GR. Effect of topically applied tocopherol on ultraviolet radiation-mediated free radical damage in skin. J Invest Dermatol 1995; 104 (4): 484-8. http://dx.doi.org/10.1111/1523-1747.ep12605921

Beijersbergen van Henegouwen GM, Junginger HE, de Vries H. Hydrolysis of RRR-alpha-tocopheryl acetate (vitamin E acetate) in the skin and its UV protecting activity (an in vivo study with the rat). J Photochem Photobiol B 1995; 29(1): 45-51. http://dx.doi.org/10.1016/1011-1344(95)90251-1

Chung CJ, Pu YS, Chen YT, Su CT, Wu CC, Shiue HS, et al. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma. Sci Total Environ 2011; 409(6): 1039-45. http://dx.doi.org/10.1016/j.scitotenv.2010.11.037

Jeong NH, Song ES, Lee JM, Lee KB, Kim MK, Cheon JE, et al. Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta Obstet Gynecol Scand 2009; 88(4): 457-62. http://dx.doi.org/10.1080/00016340902807215

Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, Wu X. Plasma vitamins E and A and risk of bladder cancer: a case-control analysis. Cancer Causes Control 2008; 19(9): 981-92. http://dx.doi.org/10.1007/s10552-008-9165-2

Jenab M, Riboli E, Ferrari P, Friesen M, Sabate J, Norat T, et al. Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. Br J Cancer 2006; 95(3): 406-15. http://dx.doi.org/10.1038/sj.bjc.6603266

Burgess JF, Pritchard JE. Tocopherols. Arch Dermatol Syph 1948; 57: 953-64. http://dx.doi.org/10.1001/archderm.1948.01520190032005

Grubb E. Our experience with vitamin E treatment. Acta Derm Venereol (Stockh) 1952; 32: 256-8.

Welch AL. Treatment by combined use of massive amounts of pantothenic acid and vitamin E in lupus erythematosus. Arch Dermatol 1954; 70(2): 181-98. http://dx.doi.org/10.1001/archderm.1954.01540200041004

Ayres S Jr, Mihan R. Lupus erythematosus and vitamin E: an effective and non-toxic therapy. Cutis 1979; 23: 49-53.

Ayres S Jr, Mihan R. Vitamin E and dermatology. Cutis 1975; 16: 1017-21.

Norton L. Further observations on the yellow nail syndrome with therapeutic effects of oral alpha-tocopherol. Cutis 1985; 36: 457-62.

Ayres S Jr, Mihan R. Yellow nail syndrome: response to vitamin E. Arch Dermatol 1973; 108: 267-8. http://dx.doi.org/10.1001/archderm.1973.01620230063024

Machlin LJ, Brin M. In: Altin-Fluter R, Krichevsky D, Eds. Nutrition and adult micronutrients. New York: Plenum Press 1980; p. 261.

Shearer MJ, Fu X, Booth SL. Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv Nutr. 2012 Mar 1; 3(2): 182-95. http://dx.doi.org/10.3945/an.111.001800

Ferland G. The discovery of vitamin K and its clinical applications. Ann Nutr Metab 2012; 61(3): 213-8. http://dx.doi.org/10.1159/000343108

Price CT, Langford JR, Liporace FA. Essential Nutrients for Bone Health and a Review of their Availability in the Average North American Diet. Open Orthop J 2012; 6: 143-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330619/

Vermeer C. Vitamin K. the effect on health beyond coagulation - an overview. Food Nutr Res 2012; 56. Epub 2012 Apr 2. http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3321262/

Hogenbirk K, Peters M, Bouman P, Sturk A, Büller HA. The effect of formula versus breast feeding and exogenous vitamin K1 supplementation on circulating levels of vitamin K1 and vitamin K-dependent clotting factors in newborns. Eur J Pediatr 1993; 152: 72-4. http://dx.doi.org/10.1007/BF02072521

Lulseged S. Haemorrhagic disease of the newborn: a review of 127 cases. Ann Trop Paediatr 1993; 13: 331-6.

Loughnan P, McDougall P. Epidemiology of late onset haemorrhagic disease: a pooled data analysis. J Paediatr Child Health 1993; 29: 177-81. http://dx.doi.org/10.1111/j.1440-1754.1993.tb00480.x

Widdershoven J, van Munster P, De Abreu R, Bosman H, van Lith T, van der Putten-van Meyel M, et al. Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II). Clin Chem 1987; 33 (11): 2074-8. http://www.clinchem. org/content/33/11/2074.long

Wojcik A, Atkins M, Mager DR. Dietary intake in clients with chronic wounds. Can J Diet Pract Res 2011; 72(2): 77-82. http://dx.doi.org/10.3148/72.2.2011.77

Yoshikawa H, Yamazaki S, Watanabe T, Abe T. Vitamin K deficiency in severely disabled children. J Child Neurol 2003; 18(2): 93-7. http://dx.doi.org/10.1177/08830738030180020801

Downloads

Published

2013-06-30

How to Cite

Chiricozzi, A., Chimenti, M. S., Bavetta, M., Babino, G., Chimenti, S., & Saraceno, R. (2013). Use of Vitamins and their Derivates in the Treatment of Cutaneous Disorders. Journal of Nutritional Therapeutics, 2(2), 59–73. https://doi.org/10.6000/1929-5634.2013.02.02.1

Issue

Section

Articles